Magovcevic-Liebisch Ivana

CIK 00012792817 companiesWATERTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001279281

Recent Transactions

50 trades

Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2026-06-17+20,275→ 20,275 total
Award
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2026-05-18+9,366→ 9,366 total
Award
Quanterix Corp$QTRX
Common Stock
2026-01-02+23,372→ 43,607 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Common Stock
2025-08-05−222,687→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2025-08-05−369,351→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2025-08-05−485,000→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2025-08-05−210,629→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2025-08-05−463,000→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2025-08-05−282,000→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2025-08-05−43,271→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2025-08-05−405,494→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2025-08-05−370,000→ 0 total
Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2025-06-13+20,275→ 20,275 total
Award
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2025-03-03+485,000→ 485,000 total
Award
Quanterix Corp$QTRX
Stock Option (Right to Buy)
2025-01-02+15,821→ 15,821 total
Award
Quanterix Corp$QTRX
Common Stock
2025-01-02+7,435→ 20,235 total
Purchase
Vigil Neuroscience, Inc.
Common Stock
2024-12-19$1.68/sh+5,000→ 222,687 total
Purchase
Vigil Neuroscience, Inc.
Common Stock
2024-12-18$1.67/sh+5,000→ 217,687 total
Purchase
Vigil Neuroscience, Inc.
Common Stock
2024-12-05$2.34/sh+5,000→ 212,687 total
Award
Quanterix Corp$QTRX
Common Stock
2024-10-02+12,800→ 12,800 total
Award
Quanterix Corp$QTRX
Common Stock
2024-10-02+27,689→ 27,689 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2024-05-03−282,000→ 0 total
Award
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2024-05-03+370,000→ 370,000 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2024-05-03−370,000→ 0 total
Award
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2024-05-03+282,000→ 282,000 total
Award
Vigil Neuroscience, Inc.
Stock Option Grant (Right to Buy)
2024-03-01+463,000→ 463,000 total
Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2024-02-08+32,500→ 32,500 total
Purchase
Vigil Neuroscience, Inc.
Common Stock
2023-11-20$3.75/sh+4,000→ 207,687 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (right to buy)
2023-06-22+1,950,000→ 1,950,000 total
Award
Vigil Neuroscience, Inc.
Stock Option Grant (Right to Buy)
2023-03-01+370,000→ 370,000 total
Award
Absci Corp$ABSI
Stock Option (right to buy)
2022-06-08+28,700→ 28,700 total
Award
Spyre Therapeutics, Inc.$SYRE
Director Stock Option (right to buy)
2022-06-07+43,000→ 43,000 total
Purchase
Vigil Neuroscience, Inc.
Common Stock
2022-05-03$3.94/sh+1,000→ 203,687 total
Purchase
Vigil Neuroscience, Inc.
Common Stock
2022-05-02$3.61/sh+4,000→ 202,687 total
Award
Vigil Neuroscience, Inc.
Stock Option Grant (Right to Buy)
2022-03-01+282,000→ 282,000 total
Award
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (right to buy)
2021-11-30+14,000→ 14,000 total
Award
Spyre Therapeutics, Inc.$SYRE
Director Stock Option (right to buy)
2021-06-08+40,000→ 40,000 total
Award
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (right to buy)
2020-12-16+12,000→ 12,000 total
Award
Spyre Therapeutics, Inc.$SYRE
Director Stock Option (right to buy)
2020-06-08+28,100→ 28,100 total
Award
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (right to buy)
2019-12-04+10,000→ 10,000 total
Award
Spyre Therapeutics, Inc.$SYRE
Director Stock Option (right to buy)
2019-06-07+12,400→ 12,400 total
Award
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (right to buy)
2018-11-15+10,000→ 10,000 total
Award
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (right to buy)
2018-07-25+10,000→ 10,000 total
Award
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (right to buy)
2018-07-25+8,000→ 8,000 total
Award
Spyre Therapeutics, Inc.$SYRE
Director Stock Option (right to buy)
2018-03-22+36,800→ 36,800 total
Award
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (right to buy)
2017-02-28+8,000→ 8,000 total
Purchase
APPLIED GENETIC TECHNOLOGIES CORP
Common Stock
2016-11-16$9.63/sh+3,000→ 3,000 total
Award
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (right to buy)
2015-11-19+6,200→ 6,200 total
Award
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (Right to Buy)
2014-12-19+4,688→ 4,688 total
Award
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (right to buy)
2014-07-11+9,375→ 9,375 total

Companies

Recent Filings

Address

C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100

WATERTOWN, MA, 02472

View on SEC.gov